ANION SECRETION DRIVES FLUID SECRETION BY MONOLAYERS OF CULTURED HUMAN POLYCYSTIC CELLS

被引:63
作者
MANGOOKARIM, R [1 ]
YE, M [1 ]
WALLACE, DP [1 ]
GRANTHAM, JJ [1 ]
SULLIVAN, LP [1 ]
机构
[1] UNIV KANSAS, MED CTR, DEPT MED, KANSAS CITY, KS 66160 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY | 1995年 / 269卷 / 03期
关键词
POLYCYSTIC KIDNEY CELLS; CHLORIDE TRANSPORT; MADIN-DARBY CANINE KIDNEY CELLS; ADENOSINE; 3'; 5'-CYCLIC MONOPHOSPHATE; BUMETANIDE; DIPHENYLAMINE-2-CARBOXYLATE; TRANSEPITHELIAL ELECTRICAL PROPERTIES;
D O I
10.1152/ajprenal.1995.269.3.F381
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
We have investigated the hypothesis that active anion transport drives fluid secretion by the cystic epithelium in autosomal dominant polycystic kidney disease (ADPKD). We prepared monolayers of a primary culture derived from cystic tissue removed from ADPKD patients. The monolayers were grown on permeant supports, and fluid secretion was initiated by forskolin. The results were compared with those obtained with monolayers of Madin-Darby canine kidney (MDCK) cells, known to secrete Cl-. In the absence of the agonist, ADPKD monolayers absorbed fluid (0.20 +/- 0.02 mu l . cm surface area(-2). h(-1)). Forskolin reversed this to secretion (0.60 +/- 0.03 mu l . cm(-2). h(-1)). Control MDCK monolayers did not transport fluid in either direction, but forskolin induced secretion (0.48 +/- 0.03 mu l . cm(-2). h(-1)). The electrical properties of the monolayers were monitored in Ussing chambers. Forskolin increased the transepithelial potential difference (V-te) of ADPKD monolayers (-0.9 +/- 0.1 to -1.1 +/- 0.1 mV) and the short-circuit current (I-sc) (6.6 +/- 0.7 to 9.2 +/- 0.8 mu A/cm(2)). The transepithelial resistance (R(te)) fell (156 +/- 9 to 138 +/- 10 Omega . cm(2)). Similar results were obtained with MDCK monolayers. The polarity of V-te and the direction of the I-sc are compatible with the hypothesis that active secretion of anion drives fluid secretion. Basolateral application of the Na-K-2Cl cotransporter, bumetanide, reduced forskolin-stimulated fluid secretion by ADPKD monolayers (0.56 +/- 0.05 to 0.28 +/- 0.03), depolarized V-te, and inhibited I-sc without affecting R(te). Apical application of the Cl- channel blocker, diphenylamine-2-carboxylate, also inhibited fluid secretion by ADPKD monolayers (0.65 +/- 0.03 to 0.27 +/- 0.02 mu l . cm(-2). h(-1)). It also depolarized V-te and decreased I-sc. The two inhibitors exerted similar effects on MDCK monolayers. These results substantiate the hypothesis that active transepithelial transport of anion may drive fluid secretion into ADPKD cysts.
引用
收藏
页码:F381 / F388
页数:8
相关论文
共 27 条
[1]   DEMONSTRATION THAT CFTR IS A CHLORIDE CHANNEL BY ALTERATION OF ITS ANION SELECTIVITY [J].
ANDERSON, MP ;
GREGORY, RJ ;
THOMPSON, S ;
SOUZA, DW ;
PAUL, S ;
MULLIGAN, RC ;
SMITH, AE ;
WELSH, MJ .
SCIENCE, 1991, 253 (5016) :202-205
[2]   CALCIUM AND CAMP ACTIVATE DIFFERENT CHLORIDE CHANNELS IN THE APICAL MEMBRANE OF NORMAL AND CYSTIC-FIBROSIS EPITHELIA [J].
ANDERSON, MP ;
WELSH, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (14) :6003-6007
[3]   CHEMICAL PROBES FOR ANION TRANSPORTERS OF MAMMALIAN-CELL MEMBRANES [J].
CABANTCHIK, ZI ;
GREGER, R .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (04) :C803-C827
[4]  
CARONE FA, 1994, LAB INVEST, V70, P648
[5]   ON THE PROBABILITY THAT KIDNEYS ARE DIFFERENT IN AUTOSOMAL DOMINANT POLYCYSTIC DISEASE [J].
GARDNER, KD ;
BURNSIDE, JS ;
SKIPPER, BJ ;
SWAN, SK ;
BENNETT, WM ;
CONNORS, BA ;
EVAN, AP .
KIDNEY INTERNATIONAL, 1992, 42 (05) :1199-1206
[6]   WHY RENAL CYSTS GROW [J].
GARDNER, KD ;
GLEW, RH ;
EVAN, AP ;
MCATEER, JA ;
BERNSTEIN, J .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (03) :F353-F359
[7]   COMPOSITION OF FLUID IN 12 CYSTS OF A POLYCYSTIC KIDNEY [J].
GARDNER, KD .
NEW ENGLAND JOURNAL OF MEDICINE, 1969, 281 (18) :985-&
[8]  
GRANT ME, 1991, J AM SOC NEPHROL, V2, P219
[9]   IN-VITRO FLUID SECRETION BY EPITHELIUM FROM POLYCYSTIC KIDNEYS [J].
GRANTHAM, JJ ;
YE, M ;
GATTONE, VH ;
SULLIVAN, LP .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (01) :195-202
[10]  
GRANTHAM JJ, 1993, J AM SOC NEPHROL, V3, P1843